A63162
A63162 is a specific 5-lipoxygenase (5-LOX) inhibitor. A63162 inhibits mitogen (PHA) -induced horse mononuclear cell (BMC) proliferation and inhibits Calcimycin -induced leukotriene LTB4 synthesis at the same concentration. A63162 can be used in the study of chronic obstructive pulmonary disease, arthritis and inflammatory bowel disease[1].
Product Specifications
CAS Number
111525-11-2
UNSPSC
12352005
Target
Leukotriene Receptor; Lipoxygenase
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/a63162.html
Smiles
CC(N(C(C)C1=CC=C(C=C1)OCC2=CC=CC=C2)O)=O
Molecular Formula
C17H19NO3
Molecular Weight
285.34
References & Citations
[1]Olsen S C, et al. Inhibition of equine mononuclear cell proliferation and leukotriene B4 synthesis by a specific 5-lipoxygenase inhibitor, A-63162[J]. American journal of veterinary research, 1992, 53 (6) : 1015-1018.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY422588 100 µg
Myelin Basic Protein (MBP) (NM_001025101) Human Over-expression Lysate
Sign In for Pricing
View Details